drugset / Trial / NCT02687646
Clinical Trial With MSC for Graft Versus Host Disease Treatment
Phase 1/2
Completed
16 enrolled
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
Andalusian Initiative for Advanced Therapies · collab
NaSingle-groupOpen-labelTreatment
Summary
Sequential administration of MSCs obtained from adipose tissue is an effective and safe treatment for acute graft versus host disease refractory to first-line treatment. Furthermore the infusion of these cells produces a biological pattern in patients that relates to the clinical response.
Timeline
- Start
- 2017-02-20
- Primary completion
- 2022-01-21
- Completion
- 2022-01-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adult Allogeneic Mesenchymal cells from adipose tissue. | Cell therapy | 700000 cells/kg | Intravenous |
| Subject | Adult Allogeneic Mesenchymal cells from adipose tissue. | Cell therapy | 1e+06 cells/kg | Intravenous |